De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: The M. D. Anderson and Mayo Clinic experience

Constantine S. Tam, Tait D. Shanafelt, William G. Wierda, Lynne V. Abruzzo, Daniel L. Van Dyke, Susan O'Brien, Alessandra Ferrajoli, Susan A. Lerner, Alice Lynn, Neil E. Kay, Michael J. Keating

Research output: Contribution to journalArticlepeer-review

139 Scopus citations

Fingerprint

Dive into the research topics of 'De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: The M. D. Anderson and Mayo Clinic experience'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds